Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002 - Wikidata - awgldk - TriplyDB

Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002

Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002

http://www.wikidata.org/entity/Q35073335

about

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 The growing burden of antimicrobial resistance.Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission.Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues Citrobacter spp. simultaneously harboring blaCTX-M, blaTEM, blaSHV, blaampC, and insertion sequences IS26 and orf513: an evolutionary phenomenon of recent concern for antibiotic resistance.First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States Comparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli and Klebsiella isolates from intensive care unit patients and the utility of whole-genome sequencing in health care settings Antibiotic resistance gene abundances associated with waste discharges to the Almendares River near Havana, Cuba Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity Identification of nasal colonization with β-lactamase-producing Enterobacteriaceae in patients, health care workers and students in Madagascar Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance Two novel class I integron arrays containing IMP-18 metallo-β-lactamase gene in Pseudomonas aeruginosa clinical isolates from Puerto Rico.Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.Appearance of β-lactam Resistance Genes in Agricultural Soils and Clinical Isolates over the 20th Century.Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical Centers Isolation and Characterization of Antimicrobial-Resistant Nontyphoidal Salmonella enterica Serovars from Imported Food Products.Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community.Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit Evaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.First outbreak of multidrug-resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum beta-lactamase and DHA-1-type AmpC beta-lactamase at a Korean hospital.Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases Multiresistant Enterobacteriaceae: new threat of an old problem.AmpC beta-lactamases.Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.Increased waterborne blaNDM-1 resistance gene abundances associated with seasonal human pilgrimages to the upper ganges river.Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009.KPC screening by updated BD Phoenix and Vitek 2 automated systems.Tackling antimicrobial resistance in lower urinary tract infections: treatment options.Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms.In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.Antimicrobial Resistance and Cytotoxicity of Citrobacter spp. in Maanshan Anhui Province, China.Genetic environment of the KPC gene in Acinetobacter baumannii ST2 clone from Puerto Rico and genomic insights into its drug resistance.Emergency (clonal spread) of methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum (ESBL)--and AmpC beta-lactamase-producing Gram-negative bacteria infections at Pediatric Department, Bosnia and Herzegovina.Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases.Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis.

P2860

Q28298371-9A9571F8-57F8-4848-98B8-C95AA3D6851D Q30371239-A68E44E6-094E-451D-BB97-53024CABBF00 Q33686219-A04770F4-8AFE-4473-8113-13CEF5FFFB09 Q33769534-3333CE5D-4C9E-4168-ABB8-E7CCA393F93B Q33827060-D167C2E4-08FB-4A63-A213-DABF84DB852C Q34045397-D8A6E5C9-FA56-4893-8A04-1C5D30FD8F53 Q34058030-28A142F2-6E3E-4563-BB51-5FE70C921E26 Q34505354-871F3620-EAAD-482E-8E92-C629902B42FD Q34752032-0A634617-6415-4591-B94E-4CF41002E004 Q35213565-25573C62-4DFD-4579-AF37-194EB425E178 Q35493039-DAB16731-483A-44BD-ACD9-50AAC7AB1D8B Q35681590-56329691-5728-457B-A90F-952318A91E84 Q35867419-F7584337-3818-42DF-8015-FA60330F0CD0 Q35912800-564F5CE9-210F-4031-86F1-070644E0A885 Q35924144-C09CD576-1F46-4C4D-9587-38FF1AEEE249 Q35993279-4E76B5A5-4A64-4407-B842-96BCA19BC90E Q36096711-A1D77065-E3C4-4903-BBD2-16087829AEED Q36744818-1CA5EFAB-21B8-48EB-9063-FAB2E12AE6A2 Q36870786-4EF82587-2482-424C-914B-5EEBBE214A13 Q36932909-8991A8FE-3E6E-47AB-B8D0-51FF408731A1 Q37021378-58694E88-D061-4504-9167-4694F4264440 Q37032817-2D9A1D6F-4772-483D-83D5-B19E544A033A Q37040812-0929715B-6D8F-4818-BA8A-C01F36EDF6D4 Q37144824-3EBC6BE6-64CB-4322-9180-CA14DD54ABD9 Q37291349-89582106-5E78-4B1B-A3F1-CE47B0EC5FE3 Q37366249-69091232-F74A-46A6-8689-9A16C92B081A Q37612954-2E73973F-6DF5-471E-88E4-F9D05E097FF3 Q37623473-71DB9A66-6F50-4B98-8C41-8C15F2F8E5DD Q38063968-56188B18-E07F-4EE0-96C4-3702D2338E18 Q38126815-13DB0383-080E-454A-92D6-EBAC63E69F2D Q38285014-38EB5F6A-6351-42E8-9C52-BF6A7C784A20 Q38833839-1F1C6CD9-9F26-4757-A8A9-301FBD7CC24B Q39762100-50A5FCFD-CC04-431C-805A-F1437DEFE164 Q40049619-FAF7A12C-459E-49E5-AE9C-583A5BB83AF5 Q40107281-D912AC8A-BDB1-4AFC-9552-37AF46C9B308 Q40646501-136B7932-F21A-4049-814A-97046AF58149 Q41751870-B1F95EB7-5D43-479E-9174-277B9F04D4E1 Q41939169-7FA9554B-32AE-4FDA-82AD-84969DE3C7AE Q41995038-311BB61C-3403-4A29-A4F5-6266042C157D Q42016476-20CEBD59-4AAA-45CE-A8C8-B13ED02AB088

P2860

Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002

http://www.wikidata.org/entity/Q35073335

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Prevalence of newer beta-lacta ...... nited States from 2001 to 2002

@ast

Prevalence of newer beta-lacta ...... nited States from 2001 to 2002

@en

type

label

Prevalence of newer beta-lacta ...... nited States from 2001 to 2002

@ast

Prevalence of newer beta-lacta ...... nited States from 2001 to 2002

@en

prefLabel

Prevalence of newer beta-lacta ...... nited States from 2001 to 2002

@ast

Prevalence of newer beta-lacta ...... nited States from 2001 to 2002

@en

P1433

Q35073335-097C166E-B4F4-4047-B039-77E2152412A2

P1476

Q35073335-5EC29A49-6178-44BC-8665-40C4033C66FA

P2093

Q35073335-26C075F1-B70B-4A21-9C67-7837B228CD0A

Q35073335-422317ED-7EA4-4C2F-A046-F91CA10BFC33

Q35073335-6506DACE-339E-4B66-9F09-44B5D470B3E9

Q35073335-BCE8E880-6391-42EF-A5E8-C0CF3BFB475D

Q35073335-BF184B00-0BA9-4F2E-A25E-80DF6BAF6011

Q35073335-C2F1D791-0E6D-4A58-83A8-A1BC915171C2

P2860

Q35073335-0A250E16-890E-46D5-B9F9-94D42CE11D6A

Q35073335-12F0B81B-69C3-43C4-8265-519D95FF235D

Q35073335-1905CE52-3E9D-4AE5-99AF-BC8FBE128E90

Q35073335-1C4300E2-191D-412C-A90F-446F60565D20

Q35073335-1E3BABE9-A6F3-4601-BA76-AE35BF1E7188

Q35073335-21B5BBA5-E540-4886-8F87-E930A4E8A2E1

Q35073335-249C85D4-B44C-4427-A98F-2F1C935205CB

Q35073335-270901DE-E09A-4C38-8AEE-D670ACE67172

Q35073335-278B1171-0F82-4504-93CF-8429AE7CA574

Q35073335-2BF8157B-DED1-4C92-AB18-D55F54029F73

P304

Q35073335-B3C94033-213C-4DD2-9F25-09273F073A37

P31

Q35073335-E80AC5F4-2EB6-4099-A957-A9A1CE76A927

P356

Q35073335-41B52354-E363-45A4-BACF-EFC2F6C5FB60

P407

Q35073335-51896B23-3FA1-4B18-9F63-0670FDC6DC5E

P433

Q35073335-85658DF3-BACA-49AC-ADBC-2DDA3B82CF32

P478

Q35073335-EBFE8D81-98B9-4DCC-B602-55AC02024433

P577

Q35073335-0E66B9DC-8B31-4920-A72C-C3F0E888ABA6

P698

Q35073335-67D4B36F-00CD-4F84-A868-C6F5099DEC9A

P921

Q35073335-ABE98DDD-EDEB-4B79-AF27-1A5FFF250D11

Q35073335-EB84F77A-1D3F-4864-9FAE-F93738215967

P932

Q35073335-DA18B2E1-5FA0-404A-9E1B-2BF263A1EAEB

P356

P1433

Journal of Clinical Microbiology

P1476

Prevalence of newer beta-lacta ...... nited States from 2001 to 2002

@en

P2093

Ashfaque Hossain

http://www.w3.org/2001/XMLSchema#string

Ellen S Moland

http://www.w3.org/2001/XMLSchema#string

Jennifer A Black

http://www.w3.org/2001/XMLSchema#string

Kenneth S Thomson

http://www.w3.org/2001/XMLSchema#string

Nancy D Hanson

http://www.w3.org/2001/XMLSchema#string

Wonkeun Song

http://www.w3.org/2001/XMLSchema#string

P2860

Extended-spectrum beta-lactamases: a clinical update

Plasmid-determined AmpC-type beta-lactamases.

Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

Metallo-beta-lactamases: the quiet before the storm?

First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States

Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.

Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.

Controversies about extended-spectrum and AmpC beta-lactamases.

Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

P304

3318-3324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00756-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16954267

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

Gram-negative bacteria

P932

1594717

http://www.w3.org/2001/XMLSchema#string